ÌÇÐÄvlog

This cohort study compares disparities in radiation and hormone therapy between women with breast cancer covered by Medicaid and those with private insurance using the Colorado Central Cancer Registry and data supplemented with All Payer Claims Data.

This proof-of-concept study examines whether a data-driven, quantitative approach can work to help identify and prioritize opportunities in biomedical product innovation for medical disorders with high public health burden and high health care costs.

This cohort study examines changes in probiotic use among neonates with very low birth weight in US neonatal intensive care units (NICUs) between 2012 and 2019 and the association of routine probiotic use in this population with health outcomes.

This cross-sectional study examines how the use of Medicare and Medicaid services and spending by payer differ across need-based subgroups.

This cohort study examines whether there were overall and telehealth addiction treatment utilization differences by age, race, ethnicity, and socioeconomic status during the early phase of the COVID-19 pandemic.

This economic evaluation study includes a cost-effectiveness analysis and compares interventions associated with increased buprenorphine treatment initiation, duration, and capacity.

This cohort study investigates out-of-pocket spending for ultra-expensive drugs in the Medicare Part D program vs commercial insurance from 2013 through 2019.

This cross-sectional study uses US county-level pharmacy claims data to examine the association of selected state policies with rates of buprenorphine treatment.

This secondary analysis of a randomized clinical trial aims to determine the effect of eliminating out-of-pocket medication fees on total health care costs across 9 primary care sites in Ontario, Canada.